JobeA.The role of surfactant therapy in neonatal respiratory distress. Respir Care1991 (in press).
2.
MilnerAD. Lung function testing in infancy. Arch Dis Child1990;65:548–552.
3.
MortolaJP, SaettaM.Measurement of respiratory mechanics in the newborn: A simple approach. Pediatr Pulmonol1987;3:123–30.
4.
MilnerAD, SaundersRA, HopkinIE. Relationship of intraoesophageal pressure to mouth pressure during the measurement of thoracic gas volume in the newborn. Biol Neonate1978;33:314–319.
5.
RadfordM.Measurement of airways resistance and thoracic gas volume in infancy. Arch Dis Child1974;49:611–615.
6.
TepperRS, PagtakhanRD, TaussigLM. Non-invasive determination of total respiratory compliance in infants by the weighted spirometer method. Am Rev Respir Dis1984;130:461–466.
7.
GaultierC, BouceM, AllaireY, ClementA, GirardF.Growth of lung volumes during the first three years of life. Bull Eur Physiopathol Respir1979;15:1103–1116.
8.
MortolaJP, FisherJT, SmithB, FoxG, WeeksS.Dynamics of breathing in infants. J Appl Physiol1982;52:1209–1215.
9.
TaussigLM, LandauLI, GodfreyS, AradI.Determinants of forced expiratory flows in newborn infants. J Appl Physiol1982;53:1220–1227.
10.
HoskynsEW, MilnerAD, HopkinsIE. Validity of forced expiration volume loops in neonates. Arch Dis Child1987;62:895–900.
11.
MotoyamaEK. Pulmonary mechanics during early postnatal years. Pediatr Res1977;11:220–223.
12.
NussbaumE, GalantSP. Measurement of total respiratory resistance in children by a modified forced oscillation method. Pediatr Res1984;18:139–145.
13.
CogswellJJ. Forced oscillation technique for determination of resistance to breathing in children. Arch Dis Child1973;48:259–266.
14.
KellyHW. Pharmacotherapy of pediatric lung disease: Differences between children and adults. Clin Chest Med1987;8:681–694.
15.
BoreusLO. Principles of pediatric clinical pharmacology. New York: Churchill Livingstone, 1982.
MirkinBL. Clinical pharmacology and therapeutics: A pediatric perspective. Chicago: Year Book Medical Publishers, 1978.
18.
AveryGB, ed. Neonatology: Pathophysiology and management of the newborn. 3rd ed. Philadelphia: JB Lippincott Co, 1987.
19.
KlausMH, FanaroffAA. Care of the high-risk neonate. Philadelphia: WB Saunders, 1973.
20.
PagliaroLA, PagliaroAM, eds. Problems in pediatric drug therapy. 2nd ed. Hamilton IL: Drug Intelligence Publications, 1987.
21.
YehTF, ed. Drug therapy in the neonate and small infant. Chicago: Year Book Medical Publishers, 1985.
22.
DupuisLL, SpinoM.Drug dosing in infants and children. In: PagliaroLA, PagliaroAM, eds. Problems in pediatric drug therapy. Hamilton IL: Drug Intelligence Publications, 1987:559–645.
23.
BoerthRC. Decreased sensitivity of newborn myocardium positive inotropic effects of ouabain. In: MorselliPL, GarattiniS, SereniF, eds. Basic and therapeutic aspects of perinatal pharmacology. New York: Raven Press, 1975:191–199.
24.
ReedMD, BesunderJB. Developmental pharmacology: Ontogenic basis of drug disposition. Pediatr Clin North Am1989;36:1053–1074.
25.
BesunderJB, ReedMD, BlumerJL. Principles of drug biodisposition in the neonate: A critical evaluation of the pharmacokinetic-pharmacodynamic interface. Clin Pharmacokinet1988;14:189–216,261–286.
26.
WellingPG. Pharmacokinetics: Processes and mathematics. Washington DC: American Chemical Society, 1986.
27.
GuptaM, BransYW. Gastric retention in neonates. Pediatrics1978;62:26–29.
28.
Friis-HansenB.Water distribution in the foetus and newborn infant. Acta Paediatr Scand1983;305(Suppl):7–11.
OgilvieRI. Clinical pharmacokinetics of theophylline. Clin Pharmacokinet1978;3:267–293.
31.
ZoppiG, AndreottiG, Pajno-FerraraF, NjaiDM, GaburroD.Exocrine pancreatic function in premature and full-term neonates. Pediatr Res1972;6:880–886.
32.
SimonGL, GorbachSL. Intestinal flora in health and disease. Gastroenterology1984;86:174–193.
33.
LongSS, SwensonRM. Development of anaerobic fecal flora in healthy newborn infants. J Pediatr1977;91:298–301.
34.
NussbaumE, EyzaguirreM, GalantSP. Dose-response relationship of inhaled metaproterenol sulfate in preschool children with mild asthma. Pediatrics1990;85:1072–1075.
35.
RowePC, ed. The Harriet Lane Handbook. 11th ed. Chicago: Year Book Medical Publishers, 1987.
36.
HenJJr. Beta adrenergic bronchodilators. Am J Asthma & Allergy Pediatricians1987;1:44–48.
37.
McWilliamsB, KellyHW, MurphyS.Management of acute severe asthma. Am J Asthma & Allergy Pediatricians1987;1:15–21.
38.
CannyGJ, LevisonH.Aerosols—Therapeutic use and delivery in childhood asthma. Ann Allergy1988;60:11–19.
39.
TabachnikE, LevisonH.Clinical application of aerosols in pediatrics. Am Rev Respir Dis1980;122(Part 2):97–103.
Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. JAMA1991;265:1637–1644.
42.
PostDJ, LambertGH. Inhaled bronchodilator use in infants: A national survey (abstract). Respir Care1989;34:1024.
43.
LoughMD, DoershukCF, SternRC. Pediatric respiratory therapy. 3rd ed. Chicago: Year Book Medical Publishers, 1985.
44.
AloanCA. Respiratory care of the newborn: A clinical manual. Philadelphia: JB Lippincott Co, 1987.
45.
KoffPB, EitzmanDV, NeuJ.Neonatal and pediatric respiratory care. St Louis: The CV Mosby Co, 1988.
46.
Gomez-Del RioM, GerhardtT, HehreD, FellerR, BancalariE.Effect of a beta-agonist nebulization on lung function in neonates with increased pulmonary resistance. Pediatr Pulmonol1986;2:287–291.
47.
MotoyamaEK, FortMD, KleshKW, MutichRL, GuthrieRD. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. Am Rev Respir Dis1987;136:50–57.
48.
MalloryGBJr, MotoyamaEK, KoumbourlisAC, MutichRL, NakayamaDK. Bronchial reactivity in infants in acute respiratory failure with viral bronchiolitis. Pediatr Pulmonol1989;6:253–259.
49.
SchuhS, CannyG, ReismanJJ, et al. Nebulized albuterol in acute bronchiolitis. J Pediatr1990;117:633–637.
50.
SchuhS, ParkinP, RajanA, et al. High- versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics1989;83:513–518.
51.
WilkieRA, BryanMH. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J Pediatr1987;111:278–282.
52.
Facts and Comparisons Division. Facts and comparisons drug information. St Louis: JB Lippincott, 1990.
53.
SteventonRD, WilsonRSE. Facemask or mouthpiece for delivery of nebulized bronchodilator aerosols?Br J Dis Chest1981;75:88–90.
54.
NewmanSP, PellowPGD, ClarkeSW. Choice of nebulisers and compressors for delivery of carbenicillin aerosol. Eur J Respir Dis1986;69:160–168.
55.
NewmanSP, PellowPGD, ClarkeSW. The flow-pressure characteristics of compressors used for inhalation therapy. Eur J Respir Dis1987;71:122–126.
56.
CannyGJ, LevisonH.Childhood asthma: A rational approach to treatment. Ann Allergy1990;64:406–416.
57.
LevisonH.Spacers in childhood asthma—Is there one for all occasions?Ann Allergy1990;64:323–324.
58.
O'CallaghanC, MilnerAD, SwarbrickA.Spacer device with face mask attachment for giving bronchodilators to infants with asthma. Br Med J1989;298:160–161.
59.
ConnerWT, DolovichMB, FrameRA, NewhouseMT. Reliable salbutamol administration in 6 to 36 month-old children by means of a metered dose inhaler and aerochamber with mask. Pediatr Pulmonol1989;6:263–267.
60.
YukselB, GreenoughA, MaconochieI.Effective bronchodilator treatment by a simple spacer device for wheezy premature infants. Arch Dis Child1990;65:782–785.
61.
LeeHS. Proper aerosol inhalation technique for delivery of asthma medications. Clin Pediatr1983;22:440–443.
62.
KellingJS, StrohlKP, SmithRL, AltoseMD. Physician knowledge in the use of canister nebulizers. Chest1983;83:612–614.
63.
NewmanSP, PaviaD, ClarkeSW. Improving the bronchial deposition of pressurized aerosols. Chest1981;80(6, Suppl):909–911.
64.
DolovichM, RuffinRE, RobertsR, NewhouseMT. Optimal delivery of aerosols from metered dose inhalers. Chest1981;80(6, Suppl):911–915.
65.
EllisEF. Bronchodilator treatment of children. In: JenneJW, MurphyS, eds. Drug therapy for asthma: Research and clinical practice. New York: Marcel Dekker Inc, 1987:837–853.
66.
PedersenS.The importance of a pause between the inhalation of two puffs of terbutaline from a pressurized aerosol with a tube spacer. J Allergy Clin Immunol1986;77:505–509.
UnzeitigJC, RichardsW, ChurchJA. Administration of metered-dose inhalers: Comparison of open- and closed-mouth techniques in childhood asthmatics. Ann Allergy1983;51:571–573.
69.
NewmanSP, PaviaD, ClarkeSW. Simple instructions for using pressurized aerosol bronchodilators. J Royal Soc Med1980;73:776–779.
70.
ConnollyCK. Method of using pressurized aerosols. Br Med J1975;3:21.
NewmanSP, MorenF, PaviaD, LittleF, ClarkeSW. Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis1981;124:317–320.
73.
NewmanSP, MillarAB, Lennard-JonesTR, MorenF, ClarkeSW. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax1984;39:935–941.
74.
PedersenS.Aerosol treatment of bronchoconstriction in children, with or without a tube spacer. N Engl J Med1983;308:1328–1330.
75.
HodgesIG, MilnerAD, StokesGM. Assessment of a new device for delivering aerosol drugs to asthmatic children. Arch Dis Child1981;56:787–789.
76.
NosedaA, YernaultJC. Sympathomimetics in acute severe asthma: Inhaled or parenteral, nebulizer or spacer?Eur Respir J1989;2:377–382.
77.
JasperAC, MohsenifarZ, KahanS, GoldbergHS, KoernerSK. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients. Chest1987;91:614–618.
78.
KimCS, EldridgeMA, SacknerMA. Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols. Am Rev Respir Dis1987;135:157–164.
79.
ZainudinBMZ, BiddiscombeM, TolfreeSEJ, ShortM, SpiroSG. Influence of size and inspiratory flow rates on the efficiency of a spacer: In vitro study (abstract). Thorax1988;43:815P.
PedersenS.Optimal use of tube spacer aerosols in asthmatic children. Clin Allergy1985;15:473–478.
82.
SilvermanM.Aerosol therapy in the newborn. Arch Dis Child1990;65:906–908.
83.
KonigP.Spacer devices used with metered-dose inhalers. Breakthrough or gimmick?Chest1985;88:276–284.
84.
PedersenS, SteffensenG.Simplification of inhalation therapy in asthmatic children. A comparison of two regimes. Allergy1986;41:296–301.
85.
PedersenS, FrostL, ArnfredT.Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy1986;41:118–124.
86.
BeckerAB, SimonsFE, BenoitTC, GillespieCA. Terbutaline by metered-dose inhaler: Conventional inhaler versus tube spacer for children with asthma. Ann Allergy1985;55:724–728.
87.
DolovichM, EngP, RuffinR, NewhouseMT. Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest1983;84:36–41.
88.
TobinMJ, JenouriG, DantaI, KimC, WatsonH, SacknerMA. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am Rev Respir Dis1982;126:670–675.
89.
HidingerKG, KjellmanNI. Childhood asthma: Improved efficacy of pressurized terbutaline aerosol by use of a 750-mL spacer. Respiration1984;45:157–160.
90.
ToogoodJH, BaskervilleJ, JenningsB, LefcoeNM, StenakeJ.Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis1984;129:723–729.
91.
PerssonG, GruvstadE, StahlE.A new multiple dose powder inhaler, (Turbuhaler), compared with a pressurized inhaler in a study of terbutaline in asthmatics. Eur Respir J1988;1:681–684.
92.
PedersenS.How to use a rotahaler. Arch Dis Child1986;61:11–14.
93.
RichardsR, SimpsonSF, RenwickAG, HolgateST. Inhalation rate of sodium cromoglycate determines plasma pharmacokinetics and protection against AMP-induced bronchoconstriction in asthma. Eur Respir J1988;1:896–901.
94.
PedersenS.Treatment of acute bronchoconstriction in children with use of a tube spacer aerosol and a dry powder inhaler. Allergy1985;40:300–304.
95.
PedersenS, HansenOR, FuglsangG.Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child1990;65:308–310.
96.
CromptonGK. New inhalation devices (editorial). Eur Respir J1988;1:679–680.
97.
FrancisPW, KellyCA, ZimmermanPV. Comparison of salbutamol powder with terbutaline aerosol administered with a tube spacer in asthmatic children. Aust Paediatr J1983;19:245–247.
98.
TownsSJ, SharotaE, SimpsonSJ, MellisCM. Bronchodilator effects of salbutamol powder administered via Rotahaler and of terbutaline aerosol administered via Misthaler. Med J Aust1983;1:633–636.
99.
ChambersS, DunbarJ, TaylorB.Inhaled powder compared with aerosol administration of fenoterol in asthmatic children. Arch Dis Child1980;55:73–74.
100.
SalmonB, WilsonNM, SilvermanM.How much aerosol reaches the lungs of wheezy infants and toddlers?Arch Dis Child1990;65:401–403.
101.
HessD.The delivery of aerosolized bronchodilator to mechanically ventilated intubated adult patients (editorial). Respir Care1990;35:399–404.
102.
MacIntyreNR, SilverRM, MillerCW, SchulerF, ColemanRE. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med1985;13:81–84.
103.
FraserI, DuVallA, DolovichM, NewhouseMT. Therapeutic aerosol delivery in ventilator systems (abstract). Am Rev Respir Dis1981;123:107.
104.
FullerHD, DolovichMB, PosmituckG, PackWW, NewhouseMT. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Am Rev Respir Dis1990;141:440–444.
105.
CroganSJ, BishopMJ. Delivery efficiency of metered dose aerosols given via endotracheal tubes. Anesthesiol1989;70:1008–1010.
106.
FlavinM, MacDonaldM, DolovichM, CoatesG, O'BrodovichH.Aerosol delivery to the rabbit lung with an infant ventilator. Pediatr Pulmonol1986;2:35–39.
107.
BanksJL, LevensonH, CvetnicWG, NaglieRA, ZenkKE, HallmanM.Pulmonary aerosol deposition in the mechanically ventilated newborn piglet (abstract). Pediatr Res1990;27:295A.
108.
CameronD, ClayM, SilvermanM.Evaluation of nebulizers for use in neonatal ventilator circuits. Crit Care Med1990;18:866.
109.
NewmanSP, PaviaD, MorenF, SheahanNF, ClarkeSW. Deposition of pressurised aerosols in the human respiratory tract. Thorax1981;36:52–55.
110.
NewmanSP. Aerosol deposition considerations in inhalation therapy. Chest1985;88(Aug, Suppl):152S–160S.
111.
DolovichMB, KillianD, WolffRK, ObminskiG, NewhouseMT. Pulmonary aerosol deposition in chronic bronchitis: Intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis1977;115:397–402.
112.
GirardP, ClairB, CertainA, et al. Comparison of plasma concentrations of aerosolized pentamidine in nonventilated and ventilated patients with pneumocystosis. Am Rev Respir Dis1989;140:1607–1610.
113.
AhrensRC, RiesRA, PopendorfW, WieseJA. The delivery of therapeutic aerosols through endotracheal tubes. Pediatr Pulmonol1986;2:19–26.
114.
CarloWA, ChatburnRL. Neonatal respiratory care. 2nd ed. Chicago: Year Book Medical Publishers, 1988.
115.
ChungKF, JeyasinghK, SnashallPD. Influence of airway calibre on the intrapulmonary dose and distribution of inhaled aerosol in normal and asthmatic subjects. Eur Respir J1988;1:890–895.
116.
HughesJM, SaezJ.Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency. Respir Care1987;32:1131–1135.
117.
SalyerJW, ChatburnRL. Patterns of practice in neonatal and pediatric respiratory care. Respir Care1990;35:879–888.
118.
NystromGA, BrownWR, DemingDD. Aerosol generator performance characteristics in neonatal ventilator circuitry (abstract). Am Rev Respir Dis1989;139:A568.
119.
NystromGA, BrownWR, DemingDD. Effect of ventilator settings on aerosol delivery through a neonatal ventilator circuit (abstract). Pediatr Res1989;25:321A.
120.
BrownWR, NystromGA, HopperAO, DemingDD. Effect of ventilator settings on aerosol delivery through an infant ventilator (abstract). Respir Care1989;34:1025.
DahlbäckM, KarlbergIB, NerbrinkO, PrytzM, WollmerP.Deposition of tracer aerosols in the rabbit respiratory tract. J Aerosol Sci1987;18:733–736.
123.
DuncanPG, BrinkC, DouglasJS. Beta-receptors during aging in respiratory tissues. Eur J Pharmacol1982;78:45–52.
124.
CarstairsJR, NimmoAJ, BarnesPJ. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis1985;132:541–547.
125.
BarnesPJ, BasbaumCB, NadelJA. Autoradiographic localization of autonomic receptors in airway smooth muscle. Am Rev Respir Dis1983;127:758–762.
126.
PatelP, MukaiD, WilsonAF. Dose-response effects of two sizes of monodisperse isoproterenol in mild asthma. Am Rev Respir Dis1990;141:357–360.
127.
ClayMM, PaviaD, ClarkeSW. Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects. Thorax1986;41:364–368.
128.
DouglasJG, LeslieMJ, CromptonGK, GrantIWB. Is the flow rate used to drive a jet nebuliser clinically important?Br Med J1985;290:29.
129.
HadfieldJW, LoweG, WindebankWJ, BatemanJRM. Is gas flow rate clinically important for nebuliser therapy (abstract)?Thorax1984;39:240.
130.
ClayMM, PaviaD, NewmanSP, ClarkeSW. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax1983;38:755–759.
131.
HenryWD, ChatburnRL. Effects of manual versus mechanical ventilation on aerosol dose efficiency (abstract). Respir Care1988;33:914.
132.
SalyerJW, RosolowskiB, O'LoughlinL, ChatburnRL. The effect of continuous in-line nebulization on tidal volume during volume ventilation of an infant lung model (abstract). Respir Care1990;35:1121.
DahlbäckM, NerbrinkO, ArboreliusM, HanssonHC. Output characteristics from three medical nebulizers. J Aerosol Sci1986;17:563–564.
135.
CushleyMJ, LewisRA, TattersfieldAE. Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax1983;38:908–913.
136.
BlackhallMI, O'DonnellSR. A dose-response study of inhaled terbutaline administered via Nebuhaler or nebuliser to asthmatic children. Eur J Respir Dis1987;71:96–101.
137.
FuglsangG, PedersenS.Comparison of Nebuhaler and nebulizer treatment of acute severe asthma in children. Eur J Respir Dis1986;69:109–113.
138.
JenkinsSC, HeatonRW, FultonTJ, MoxhamJ.Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest1987;91:804–807.
139.
MestitzH, CoplandMJ, McDonaldCF. Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction. Chest1989;96:1237–1240.
140.
O'CallaghanC, ClarkeAR, MilnerAD. Inaccourate (sic) calculation of drug output from nebulisers. Eur J Pediatr1989;148:473–474.
141.
RooneyJC, WilliamsHE. The relationship between proven viral bronchiolitis and subsequent wheezing. J Pediatr1971;79:744–747.
142.
SotoME, SlyPD, UrenE, TaussigLM, LandauLI. Bronchodilator response during acute viral bronchiolitis in infancy. Pediatr Pulmonol1985;2:85–90.
143.
NorthwayWHJr. Bronchopulmonary dysplasia: Then and now. Arch Dis Child1990;65:1076–1081.
144.
GreenoughA.Bronchopulmonary dysplasia: Early diagnosis, prophylaxis, and treatment. Arch Dis Child1990;65:1082–1088.
145.
EigenH.Clinical pharmacology of the wheezing infant. Pediatr Ann1985;14:325–331.
146.
LevisonH, IslesA.Response: Asthma in childhood. J Allergy Clin Immunol1983;72:539–544.
147.
SilvermanM.Bronchodilators for wheezy infants?Arch Dis Child1984;59:84–87.
148.
DavisDJ, DattelBJ, BallardPL, RobertsJM. Beta-adrenergic receptors and cyclic adenosine monophosphate generation in human fetal lung. Pediatr Res1986;21:142–147.
149.
PrendivilleA, GreenS, SilvermanM.Airway responsiveness in wheezy infants: Evidence for functional Beta-adrenergic receptors. Thorax1987;42:100–104.
150.
RoanY, GalantSP. Decreased neutrophil beta adrenergic receptors in the neonate. Pediatr Res1982;16:591–593.
151.
WeissB, ClarkMB, GreenbergLH. Modulation of catecholaminergic receptors during development and aging. In: LajthaA, ed. Handbook of neurochemistry. 2nd ed. New York: Plenum Press, 1984:595–627.
152.
InselPA, MotulskyHJ. Physiologic and pharmacologic regulation of adrenergic receptors. In: InselPA, ed. Adrenergic receptors in man. New York: Marcel Dekker Inc, 1987:201–236.
153.
FraserCM, VenterJC. Beta-adrenergic receptors. Relationship of primary structure, receptor function, and regulation. Am Rev Respir Dis1990;141(Suppl):S22–S30.
154.
PhelanPD, WilliamsHE. Sympathomimetic drugs in acute viral bronchiolitis: Their effect on pulmonary resistance. Pediatrics1969;44:493–497.
155.
RutterN, MilnerAD, HillerEJ. Effects of bronchodilators on respiratory resistance in infants and young children with bronchiolitis and wheezy bronchitis. Arch Dis Child1975;50:719–722.
156.
RadfordM.Effect of salbutamol in infants with wheezy bronchitis. Arch Dis Child1975;50:535–538.
157.
LenneyW, MilnerAD. At what age do bronchodilator drugs work?Arch Dis Child1978;53:532–535.
158.
LenneyW, MilnerAD. Alpha and beta adrenergic stimulants in bronchiolitis and wheezy bronchitis in children under 18 months of age. Arch Dis Child1978;53:707–709.
159.
StokesGM, MilnerAD, HodgesIGC, HenryRL, ElphickMC. Nebulised therapy in acute severe bronchiolitis in infancy. Arch Dis Child1983;58:279–283.
160.
MatsubaK, ThurlbeckWM. A morphometric study of bronchial and bronchiolar walls in children. Am Rev Respir Dis1972;105:908–913.
161.
SlyPD, LanteriCJ, RavenJM. Do wheezy infants recovering from bronchiolitis respond to inhaled salbutamol?Pediatr Pulmonol1991;10:36–39.
162.
KaoLC, WarburtonD, PlatzkerACG, KeensTG. Effect of isoproterenol inhalation on airway resistance in chronic bronchopulmonary dysplasia. Pediatrics1984;73:509–514.
163.
SosulskiR, AbbasiS, BhutaniVK, FoxWW. Physiologic effects of terbutaline on pulmonary function of infants with bronchopulmonary dysplasia. Pediatr Pulmonol1986;2:269–273.
164.
CabalLA, LarrazabalC, RamanathanR, et al. Effects of metaproterenol on pulmonary mechanics, oxygenation, and ventilation in infants with chronic lung disease. J Pediatr1987;110:116–119.
165.
MallolJ, BarruetoL, GirardiG, MunozR, PuppoH, UlloaV, ToroO, QuevedoF.Use of nebulized bronchodilators in infants under 1 year of age. Pediatr Pulmonol1987;3:298–303.
166.
BrudnoDS, ParkerDH, SlatonG.Response of pulmonary mechanics to terbutaline in patients with bronchopulmonary dysplasia. Am J Med Sci1989;297:166–168.
167.
RotschildA, SolimanoA, PutermanM, SmythJ, SharmaA, AlbersheimS.Increased compliance in response to salbutamol in premature infants with developing bronchopulmonary dysplasia. J Pediatr1989;115:984–991.
168.
AllenJL, WolfsonMR, McDowellK, ShafferTH. Thoracoabdominal asynchrony in infants with airflow obstruction. Am Rev Respir Dis1990;141:337–342.
169.
TepperRS. Airway reactivity in infants: A positive response to methacholine and metaproterenol. J Appl Physiol1987;62:1155–1159.
170.
KraemerR, BirrerP, SennhauserFH, SchoniMH. Short-time response characteristics of salbutamol in infants with bronchopulmonary diseases. Eur J Clin Pharmacol1988;34:339–342.
171.
SchuhS, ReiderMJ, CannyG, et al. Nebulized albuterol in acute childhood asthma: Comparison of two doses. Pediatrics1990;86:509–513.
172.
MolerFW, HurwitzME, CusterJR. Improvement in clinical asthma score and Paco2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol1988;81:1101–1109.
173.
NicklasRA. Paradoxical bronchospasm associated with the use of inhaled beta agonists. J Allergy Clin Immunol1990;85:959–964.
174.
PrendivilleA, GreenS, SilvermanM.Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax1987;42:86–91.
175.
O'CallaghanC, MilnerAD, SwarbrickA.Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet1986;2:1424–1425.
176.
O'CallaghanC, MilnerAD, SwarbrickA.Paradoxical bronchoconstriction in wheezing infants after nebulised preservative free iso-osmolar ipratropium bromide. Br Med J1989;299:1433–1434.
177.
GongHJr, TashkinDP, CalvareseBM. Alcohol-induced bronchospasm in an asthmatic patient: Pharmacologic evaluation of the mechanism. Chest1981;80:167–173.
178.
BeaslyCRW, RaffertyP, HolgateST. Bronchoconstriction properties of preservatives in ipratropium bromide (Atrovent) nebulizer solution. Br Med J1987;294:1197–1198.
179.
HenryRL, MilnerAD, StokesGM. Ineffectiveness of ipratropium bromide in acute bronchiolitis. Arch Dis Child1983;58:925–926.
180.
GrogginsRC, MilnerAD, StokesGM. Bronchodilator effects of clemastine, ipratropium bromide, and salbutamol in preschool children with asthma. Arch Dis Child1981;56:342–344.
181.
HodgesIGC, GrogginsRC, MilnerAD, StokesGM. Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers. Arch Dis Child1981;56:729–732.
182.
KaoLC, DurandDJ, NickersonBG. Effects of inhaled metaproterenol and atropine on the pulmonary mechanics of infants with bronchopulmonary dysplasia. Pediatr Pulmonol1989;6:74–80.
183.
BrattebyLE, FoucardT, LonnerholmG.Combined treatment with ipratropium bromide and beta-2-adrenoceptor agonists in childhood asthma. Eur J Respir Dis1986;68:239–247.
184.
StorrJ, LenneyW.Nebulised ipratropium and salbutamol in asthma. Arch Dis Child1986;61:602–603.
185.
BrundageKL, MohsiniKG, FroeseAB, FisherJT. Bronchodilator response to ipratropium bromide in infants with bronchopulmonary dysplasia. Am Rev Respir Dis1990;142:1137–1142.
186.
WatsonWTA, BeckerAB, SimonsFER. Comparison of ipratropium solution, fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma. J Allergy Clin Immunol1988;82:1012–1018.
187.
ReismanJ, Galdes-SebaltM, KazimF, CannyG, LevisonH.Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children. J Allergy Clin Immunol1988;81:16–20.
188.
DeStefanoG, BonettiS, BonizzatoC, VallettaEA, PiacentiniGL, BonerAL. Additive effect of albuterol and ipratropium bromide in the treatment of bronchospasm in children. Ann Allergy1990;65:260–262.
189.
LewDB, HerrodHG, CrawfordLV. Combination of atropine and isoetharine aerosol therapy in pediatric acute asthma. Ann Allergy1990;64(Part II):195–200.
190.
VichyanondP, SladekWA, SurS, HillMR, SzeflerSJ, NelsonHS. Efficacy of atropine methylnitrate alone and in combination with albuterol in children with asthma. Chest1990;98:637–642.
191.
SurS, MohiuddinAA, VichyanondP, NelsonHS. A random double-blind trial of the combination of nebulized atropine methylnitrate and albuterol in nocturnal asthma. Ann Allergy1990;65:384–388.
192.
LenneyW, EvansNA. Nebulized salbutamol and ipratropium bromide in asthmatic children. Br J Dis Chest1986;80:59–65.
193.
GodfreyS, ZeidifardE, BrownK, BellJH. The possible site of action of sodium cromoglycate assessed by exercise challenge. Clin Sci Molec Med1974;46:265–272.
194.
BertelsenA, AndersenJB, BuschP, et al. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. Allergy1986;41:266–270.
195.
PrennerBM. Safety, efficacy and bronchodilator-sparing effects of nebulized cromolyn sodium solution in the treatment of asthma in children. Ann Allergy1982;49:186–190.
196.
NewthCJ, NewthCV, TurnerJA. Comparison of nebulised sodium cromoglycate and oral theophylline in controlling symptoms of chronic asthma in pre-school children: A double blind study. Aust NZ J Med1982;12:232–238.
197.
Geller-BernsteinC, LevinS.Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children. Respiration1982;43:294–298.
198.
GlassJ, ArcherLN, AdamsW, SimpsonH.Nebulised cromoglycate, theophylline, and placebo in preschool asthmatic children. Arch Dis Child1981;56:648–651.
199.
HenryRL, HillerEJ, MilnerAD, HodgesIGC, StokesGM. Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life. Arch Dis Child1984;59:54–57.
200.
O'CallaghanC, MilnerAD, SwarbrickA.Nebulised sodium cromoglycate in infancy: Airway protection after deterioration. Arch Dis Child1990;65:404–406.
201.
CorkeyC, MindorffC, LevisonH, NewthC.Comparison of three different preparations of disodium cromoglycate in the prevention of exercise-induced bronchospasm. Am Rev Respir Dis1982;125:623–626.
202.
Bar-YishayE, GurI, LevyM, VolozniD, GodfreyS.Duration of action of sodium cromoglycate on exercise induced asthma: Comparison of 2 formulations. Arch Dis Child1983;58:624–627.
203.
BundgaardA, Bach-MortensenN, SchmidtA.The effect of sodium cromoglycate delivered by Spinhaler and by pressurized aerosol on exercise-induced asthma in children. Clin Allergy1982;12:601–605.
WilsonNM, SilvermanM.Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child1990;65:407–410.
207.
OrgelHA, MeltzerEO, KempJP. Flunisolide aerosol in treatment of steroid-dependent asthma in children. Ann Allergy1983;51:21–25.
208.
MeltzerEO, KempJP, OrgelHA, IzuAE. Flunisolide aerosol for treatment of severe, chronic asthma in steroid-independent children. Pediatrics1982;69:340–345.
209.
ShapiroGG, IzuAE, FurukawaCT, PiersonWE, BiermanCW. Short-term double-blind evaluation of flunisolide aerosol for steroid-dependent asthmatic children and adolescents. Chest1981;80:671–675.
210.
FreigangB.Long-term follow-up of infants and children treated with beclomethasone aerosol by a special inhalation device. Ann Allergy1980;45:13–17.
211.
MaayanC, ItzhakiT, Bar-YishayE, GrossS, TalA, GodfreyS.The functional response of infants with persistent wheezing to nebulized beclomethasone dipropionate. Pediatr Pulmonol1986;2:9–14.
212.
TalA, BavilskiC, YohaiD, BearmanJE, GorodischerR, MosesSW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics1983;71:13–18.
213.
HallCB, McBrideJT, WalshEE. Aerosolized ribavirin treatment of infants with RSV infections: A randomized double-blind study. N Engl J Med1983;308:1443–1447.
214.
HallCB, McBrideJT, GalaCL. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA1985;254:3047–3051.
215.
TaberLH, KnightV, GilbertBE, et al. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics1983;72:613–618.
216.
American Academy of Pediatrics Committee on Infectious Diseases. Ribavirin therapy of respiratory syncytial virus. Pediatrics1987;79:475–478.
217.
SmithDW, FrankelLR, MathersLH, TangATS, AriagnoRL, ProberCG. Aerosolised ribavirin in infants requiring mechanical ventilation for severe lower respiratory tract infection caused by respiratory syncytial virus (abstract). Clin Res1991;39:59A.
218.
KacmarekRM. Ribavirin and pentamidine aerosols: Caregiver beware! (editorial). Respir Care1990;35:1034–1036.
219.
CharneyW, CorkeryKJ, KraemerR, WugofskiL.Engineering and administrative controls to contain aerosolized ribavirin: Results of simulation and application to one patient. Respir Care1990;35:1042–1048.
220.
DemersRR, ParkerJ, FrankelLR, SmithDW. Administration of ribavirin to neonatal and pediatric patients during mechanical ventilation. Respir Care1986;31:1188–1195.